The Clinical Research Of JWSGMH Prescirption In Treating Bronchial Asthm

Bronchial asthma is a common chronic disease。Today, about300million bronchial asthma patients around the world， asthmaincidence of1%in our country, children of3%.It seriously affectedthe affected People’s Daily lives, cause serious social andeconomic burden.Although controlling bronchial asthma cost seemshigh, but due to not correct treatment of higher medical costs.Aboutthe pathogenesis of asthma causes include genetic factors andenvironmental factors two aspects.Genetic factors can be reflectedin many patients,Such as the vast majority of patients relatives(near three generations),can be traced back to have asthma(repeatedly cough, wheezing) or other allergic diseases (allergicrhinitis, atopic dermatitis) history. Belong to allergicconstitution, most of the bronchial asthma patients themselvesmay be associated with allergic rhinitis and atopic dermatitis,or by air to common allergens, mites, pollen, mold, pet, etc.),certain food (milk, nuts, seafood, etc.), drug allergy, etc. Ifsevere bronchial asthma patients in acute attack, treatment maybe killed. Not in time Poorly controlled the bronchial asthma patients with its impact on the daily work and daily life happens,can lead to delays, incorrect learning and activities, limitedmovement, makes the decline in the quality of life, and bringeconomic burden, also can have a negative impact on the lives ofhis family. Bronchial asthma with repeated attacks can causechronic obstructive pulmonary disease, emphysema, lung, heartfunction failure.Objective:To investigate the clinical effect on asthma of thetreatment with Jiawei sheganmahuang prescription.Methods:This study selected Chinese Medicine Hospital ofRespiratory Medicine,Hubei Province,60cases of out-patienttreament to patients (clinically diagnosed as bronchialasthma,chronic duration),this60cases diagnosed as bronchialasthma patients were randomly divided into treament group30casesand the control group30cases,two groups of patientsbefore treatment of gender,age,duration,severity,traditionalChinese medicine symptom score,lung function,no statisticalsignificant difference (P>0.05)comparable.Treatment group, thesheganmahuang prescription (Shoot dry6ephedra asarum pinellia1010asters15schisandra10winter spend15hopu15dried tangerineor orange peel.water decoction,japan1,2servise points per dosefinisher,each200ml)combined slmeterol fluticasone propionateinhalation powder50ug/250ug (day one suction) in the treatmentand control group to be pure salmeterol fluticasone propionateinhalation powder50ug/250ug(day one suction)treatment, takinga course of treatment, both groups before and after treatment byobserving the symptoms and signs of performance and lung function, compare their efficacy.Results: Treatment group total effective rate was86.67%, totaleffective rate was73.33%in the control group.Two group of patientswith over all response rate after treatment by the statisticalP>0.05,no signficant difference. Two groups of patients withsymptomatic efficacy of TCM treatment group was significantlybetter than the control group,after statistical (P<0.05), and thetreatment groupBoth group s improved after tr eatment FEV1significant difference(P<0.01),treatment group is better thanthe control group.PEF improved with significant difference (P <0.05), the treatment group is better than the control group.